Bausch + Lomb to Participate in Upcoming Investor Conferences
VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that members of its management team will participate in two investor conferences in September:
Article content
J.P. Morgan European Leveraged Finance Conference
September 3, 2025, London, U.K.
Article content
Morgan Stanley Global Healthcare Conference
September 8, 2025, 7:45 a.m. ET, New York, NY
Article content
Executive Vice President and Chief Financial Officer Sam Eldessouky will participate in investor meetings at the J.P. Morgan conference. Chairman of the Board and Chief Executive Officer Brent Saunders and Sam Eldessouky will participate in a fireside chat at the Morgan Stanley conference.
Article content
A live webcast of the Morgan Stanley fireside chat will be available on the Investor Relations section of the Bausch + Lomb website.
Article content
About Bausch + Lomb
Article content
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit
Article content
,
Article content
Article content
,
Article content
Article content
,
Article content
X
Article content
and
Article content
YouTube
Article content
.
Article content
Article content
Article content
Article content
Contacts
Article content
Media Contact:
Article content
Article content
Chris Clark
Article content
Article content
chris.clark@bausch.com
Article content
Article content
(848) 360-1100
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
5 hours ago
- Globe and Mail
WKHS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Workhorse Group Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Workhorse Group Inc. (NASDAQ: WKHS) and Motiv Electric Trucks is fair to Workhorse shareholders. Upon completion of the proposed transaction, Workhorse shareholders will own approximately 26.5% of the combined company. Halper Sadeh encourages Workhorse shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@ or zhalper@ The investigation concerns whether Workhorse and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Workhorse shareholders; and (2) disclose all material information necessary for Workhorse shareholders to adequately assess and value the merger consideration. On behalf of Workhorse shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
CTV News
6 hours ago
- CTV News
Alberta COVID-19 vaccination program triggers confusion, criticism
Medical tools are pictured in an exam room at a health clinic in Calgary, Friday, July 14, 2023. THE CANADIAN PRESS/Jeff McIntosh Health experts, advocates and unions are sounding the alarm over Alberta's plan for paid COVID-19 shots, calling it concerning and confusing. On Monday, two months after the province announced it was adding a fee, it opened online pre-ordering for the vaccine. Albertans still need to book appointments for the shots, starting in October. Dr. James Talbot, the province's former chief medical officer of health, said the government appears to be doing everything it can to make this year's immunization campaign a 'failure' by making it less available, less accessible and less affordable. 'They are basically sabotaging their own COVID campaign,' he said. Dr. James Talbot Dr. James Talbot, co-chair of the EZMSA strategic COVID-19 pandemic committee, said in an interview with CTV News Edmonton that EZMSA has been predicting for four weeks now that variants would drive a significant third wave of COVID-19 cases (CTV News Edmonton). He's among a chorus of critics warning it could lead to more hospitalizations and stress on the health-care system. Talbot and other public health experts and physicians penned an opinion piece in the Edmonton Journal last week, arguing the plan creates unfair barriers and puts Albertans at risk. 'You've created this unfairness where if you're rich, you can get protected, but if you're poor, you may not be able to,' Talbot said. Extreme outlier Leigh Allard, president and CEO of Alberta Lung, part of the National Lung Health Alliance, said the government's policy makes it an extreme outlier and its precedent could ripple across the country. Those who suffer from lung conditions like asthma, cystic fibrosis or pulmonary fibrosis are vulnerable, she added. This year, Albertans also won't be able to walk into a pharmacy to get a COVID-19 shot, where the vast majority of doses were given last year. They must go to a public health clinic. Allard said people are confused over the plan. She's also concerned many won't be able to access a clinic for a shot, especially if hours aren't extended, or some simply won't be able to afford it. She said she expects an uptake in Alberta Lung's financial assistance programs. 'As a charity, we should not be supplementing what the government should be doing.' The government said it will still pay for some to get shots, including those who have compromised immune systems or are on social programs. Seniors in congregate settings will also be covered. However, the specifics of the qualifying health conditions have not been released. It's estimated a shot could cost $110, but the government has yet to pin down the price. Kyle Warner, spokesperson for Primary and Preventative Health Minister Adriana LaGrange, said details are forthcoming. 'The fall immunization plan is being finalized, and details — including the updated vaccination schedule, eligible conditions, exact locations and administrative fee for COVID-19 vaccines — will be available soon,' he said in a statement. Warner also said Albertans who don't pre-order by the Sept. 30 deadline can still book a vaccine appointment once doses become available. He said online pre-ordering helps determine future vaccine needs, minimize waste, manage delivery and prevent double bookings, since the influenza vaccine can be given at the same time. Those who pre-order are promised a reminder in October to book an appointment. The province said it has ordered 485,000 doses of COVID-19 vaccine for the fall and some of the estimated $49-million cost would be covered through those who have to pay. The government didn't respond to questions about whether it has a contingency plan to order more doses if needed, whether out-of-province costs might be reimbursed, and what informed its decision to order 250,000 fewer doses than last year. It also didn't clarify whether flu shots, which remain free, would be available in pharmacies. The province's interim chief medical officer of health, Dr. Sunil Sookram, wasn't made available for an interview. Disrespectful Talbot called withholding the specifics disrespectful. 'It's bad enough that there's a list that says you're going to ration it, but then to have confusion about who's on the list — that just seems cruel,' he said. The province has said an estimated one million COVID-19 vaccine doses, or just over half of Alberta's supply, weren't used during the 2023-24 respiratory virus season. Premier Danielle Smith has said that meant $135 million was 'flushed down the drain.' Facing heated questions about the policy at a public town hall in Edmonton on Thursday, Smith said her United Conservative Party government is trying not to waste public money. 'There are lots of different types of vaccines that are paid for out of pocket right now ... because the federal government defunded it,' she said, pointing to shots for yellow fever, which also need to be purchased. The latest provincial data says 394 Albertans with confirmed COVID-19 have died since last August. Talbot and labour leaders have also said the plan puts health workers in harm's way, and potentially forces those in an already strained system to take sick time off work to avoid infecting others. 'You're going to be the only province in the country that says we care so little about these people that we're going to force them to pay for their own vaccine,' said Talbot. 'It seems inconceivable to me that a rational mind would think that was a good way to recruit and retain health-care professionals.' Potential fallout Unions warned this week of potential fallout. In a Tuesday letter to the premier, Alberta Federation of Labour president Gil McGowan wrote it would be a violation of workplace health and safety laws not to include all health workers, education workers, transit operators and those in the service sector on its priority list. McGowan said he's also hearing frustration and confusion from front-line members. 'It's not just incompetence. This is clearly not a vaccine rollout strategy. It's a vaccine suppression strategy,' he said. The United Nurses of Alberta has said the plan limits the freedom of Albertans to choose vaccination by intentionally limiting supply and penalizing those who can't afford it. --Lisa Johnson This report by The Canadian Press was first published Aug. 16, 2025.
Globe and Mail
7 hours ago
- Globe and Mail
Leerink Partners Sticks to Their Buy Rating for Idexx Laboratories (IDXX)
In a report released today, Daniel Clark from Leerink Partners reiterated a Buy rating on Idexx Laboratories, with a price target of $745.00. The company's shares closed yesterday at $653.95. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Clark covers the Healthcare sector, focusing on stocks such as Elanco Animal Health, Idexx Laboratories, and Zoetis. According to TipRanks, Clark has an average return of 17.8% and a 76.92% success rate on recommended stocks. In addition to Leerink Partners, Idexx Laboratories also received a Buy from BTIG's Mark Massaro in a report issued today. However, on August 11, Piper Sandler reiterated a Hold rating on Idexx Laboratories (NASDAQ: IDXX). IDXX market cap is currently $52.32B and has a P/E ratio of 54.43. Based on the recent corporate insider activity of 51 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of IDXX in relation to earlier this year. Earlier this month, Michael G Erickson, the EVP of IDXX sold 87.00 shares for a total of $56,536.95.
